ABSTRACT
Introduction
Probiotic yeasts are non-pathogenic strains belonging to the genus Saccharomyces cerevisiae var. boulardii (20) . Probiotic cultures have been used as both a preventive and therapeutic agent for the treatment of a variety of diarrheal diseases. S. boulardii is reported to be effective in the treatment for diarrhea in adults and children infected with Clostridium difficile, for diarrhea in human immunodeficiency virus-infected patients and for acute and chronic diarrhea in children and adults (16, 20) . Potential mechanisms of probiotic activity are based on secretion of proteases or inhibitory proteins, stimulation of immunoglobulin A, acquisition and elimination of secreted toxins (8, 16) . In vitro and in vivo studies have indicated that S. boulardii is able to prevent intestinal infection caused by Escherichia coli, Salmonella Typhimurium, Staphylococcus aureus, Pseudomonas aeruginosa, Proteus vulgaris, Yersinia enterocolitica and Candida albicans (5, 16) . Furthermore, oral administration of S. boulardii leads to a distinct increase in the activity of the disaccharidases lactase, sucrase and maltase in the brush border membrane (3) .
Yeast classification is traditionally based on morphological and physiological criteria. These conventional criteria are often unable to discriminate at a subspecies level and provide doubtful identification (4, 23, 26, 27) . However, molecular methods have also recently become available. Among them karyotyping, restriction analysis of mtDNA, PCR-based techniques have been successfully applied to yeast strain typing and identification (10, 13, 21, 22) . The aim of this research was to characterize probiotic yeasts strains by classical (morphology, reproduction, biochemical features) and molecular (karyotype analysis) methods.
Materials and methods

Yeast strains
In this study nine strains of Saccharomyces boulardii were considered: two strains from the American Type Culture Collection and seven strains isolated from medicines. All the strains used in this study are listed in Table 1 
Biochemical tests
The strains were inoculated on YPD slants after activation.
The suspension of yeast cells in 0.85% NaCl with a turbidity equal to 2 McFarland scale was prepared. 100 μl of this suspension was transferred into API C medium and used to inoculate the API 20 C AUX kits (bioMerieux). The tests were performed according to the instructions of the manufacturer. After incubation the reactions were read by comparing them to growth controls. The assimilation of nitrogen compounds was determined in liquid carbon base medium (Difco) with potassium nitrite or ethylamine addition at final concentration of 5 mM (2). The growth was assessed spectrophotometrically in relation to negative (without inoculation) and positive (with NH 4 + ) control cultures.
API-ZYM tests
The strains were inoculated on YPD slopes after activation. The growth was collected in distilled water and the dense suspension formed (5 of McFarland scale) was used to inoculate the API-ZYM kits (bioMerieux). The tests were performed according to the instructions of the manufacturer. Enzyme activity was graded from 0 to 5 by comparing the colour developed within 5 min to the API-ZYM colour reaction chart.
Analysis of nuclear chromosomes
Chromosomes of yeast strains were isolated and separated by pulsed-field gel electrophoresis PFGE. The typical conditions for preparation of chromosomal DNA from the Saccharomyces yeasts were followed (24) . A CHEF-DR II apparatus (Bio-Rad) was used for separation of chromosomes. The electrophoresis gel was an agarose concentration of 0.8% and the electrophoresis buffer was 0.5 x TBE cooled to 10ºC. Electrophoresis was carried out at 6 V/cm for 26 h with a switching time increasing from 110 to 220 s. After electrophoresis the gel was stained with ethidium bromide for visualization of chromosomal DNA. A standard commercial set of S. cerevisiae YNN295 chromosomes (BioRad) was used for comparison.
Results and Discussion
All yeast strains were identified as Saccharomyces cerevisiae according to their morphological characteristics, ability to assimilate carbon and nitrogen compounds and sugar fermentation patterns. Vegetative cells of tested yeasts were cylindrical, of dimensions 2-3μm x 5-8μm. The yeasts produced no filaments in slide cultures on potato glucose medium. However, it was shown that S. boulardii strains are able to adopt a filamentous mode of growth upon exposure to a poor nitrogen source (6) .
All strains reproduced by budding, but they were unable to sporulate even after 90 days of incubation on sporulation media. The sporulation deficiency of S. boulardii was also demonstrated in other papers (6, 14, 15) . This finding could be explained by yeast chromosom IX trisomy, different copy numbers for a set of genes or sequence divergence of CDC16, DMC1 and MND2 (6).
All tested strains assimilated glucose, maltose, raffinose ( Table 2) . However, there were differences in utilization of glycerol, galactose, cellobiose and maltose. The narrowed biochemical profiles of S. boulardii with Gal+, Mal+, Raf+ phenotype was presented by McCullough et al. (14) , which is partly in agreement with our results. The ability of the yeasts to assimilate glucose, raffinose and maltose confirmed the observations of Hayford and Jespersen (11) for 48 isolates of S. cerevisiae. In our study only one strain isolated from Enterol ® was able to assimilate galactose. This finding is partially accord with states that S. boulardii does not use galactose as a carbon source (15) . However, the galactose utilization has been shown to be variable among S. cerevisiae strains (1) and as such, it is an unacceptable marker for species identification. On the base of assimilation profiles all the tested yeasts were classified as Saccharomyces cerevisiae with 96 -99% of probability, even though some variations in biochemical patterns were obtained. Strains  S1  S2  S3  S4  S5  S6  S7  S8 API-ZYM tests revealed lipolitic and proteolytic activities of yeasts. All strains exhibited alkaline phosphatase, acid phosphatase and naphthol-AS-BI-phosphohydrolase activity. In addition all strains were able to hydrolyse 2-naphthyl butyrate and 2-naphthyl caprylate, indicating esterase and esterase lipase activity. Strong leucine arylamidase activity was also detected in all the tested strains. Similar results were obtained for Saccharomyces isolates from infant faeces, Feta cheese (22) and blue veined cheese (10). The chromosomal patterns of eight strains (S2-S9) did not show polymorphism and consisted of 13 bands sized 222-2251 kb (Fig. 1) . Only the karyotype of the strain isolated from Enterol ® was distinctive with additional chromosome 1884 kb. All the strains belong to the genus Saccharomyces since they show 13-14 bands of a size varying between 200 and 2,300 kb (4, 19, 27) . The karyotypes of S. boulardii are very similar to those of S. cerevisiae, although chromosomal length polymorphism is observed in S. cerevisiae strains (7, 19, 21) . MacFarland (15) classified S. boulardii outside S. cerevisiae species on the basis of metabolic and molecular parameters. Similar results were obtained by Cardinali and Martini (4) using comparative electrophoretic karyotyping and multivariate analysis of the polymorphism observed in PFGE electrophoresis. However, Vaughan-Martini et al. (27) concluded that none of the species of genus Saccharomyces could be distinguish by the consistent presence or absence of a unique band or cluster of bands. Some taxonomic studies (2, 17, 25) have indicated that S. boulardii should be rather considered as a strain of S. cerevisiae. DNA-DNA reassociation studies indicated that this yeast was distinct from S. cerevisiae and from other species of Saccharomyces genus (4). This conclusion was subsequently challenged based on analysis of DNA polymorphism (18) specific primers showed that all strains of S. boulardii could indeed be assigned to the species of S. cerevisiae (12) . This conclusion is reflected in current nomenclature and the name S. boulardii is invalid for the International Code of Botanical Nomenclature (ICBN). According to official taxonomic definitions strains, appearing in descriptions of commercially available therapeutic products as S. boulardii, comprise the subtype of the Saccharomyces cerevisiae species and should be referred as S. cerevisiae var. boulardii.
In conclusion, phenotypic and genotypic traits showed diversity among tested strains and confirmed yeasts classification to Saccharomyces cerevisiae var. boulardii.
